Research article · 28 Feb 2022
Short communicationPublished 24 Jul 2018
Eteplirsen: Unattainable Attained
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rare diseases are highly diverse and it is critical to know the signs that predict the development, progression and manifestation of disease. Though a very small number of people get affected by the rare diseases but its impact is outrageous, Duchenne Muscular Dystrophy (DMD) being one such rare genetic disorder is characterized by progressive muscle deterioration and wasting. An overall estimate of prevalence of DMD reflects 30 per 100,000 populations (1 in 3000 or~0.029%).
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Oct 2016
On-going exon 53 skipping clinical trial for Duchenne Muscular Dystrophy
Conference abstract
Failing heart in patients suffering Duchenne muscular dystrophy: A disease animated by compromised genome of stem cells
Commentary · 31 Dec 2025
Gene Therapy Strategies and Clinical Management in Duchenne Muscular Dystrophy
Review article · 28 Jun 2024
The Use of Computer Technology and Game Therapy for the Rehabilitation of Individuals with Duchenne Muscular Dystrophy: A Review
More from this journal
The newest in Journal of Pharmaceutical Sciences & Emerging Drugs.
Research article · 18 Feb 2025
Comparative Biowaiver Study of Moxifloxacin in Immediate Release of Oral Solid Dosage Form
Perspective · 23 Aug 2024
Drug Intoxication in Adolescents: Warning Signs and Prevention
Short communication · 20 Aug 2024
Bio-organic Chemistry Approaches to Modulating Protein- Ligand Interactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mukta Sharma”
- BylineArticles whose byline prints “Naina Goel”
- BylineArticles whose byline prints “Ashwin K Jainarayanan”

